Modeling in vitro, ex vivo or in vivo?

P. Mercer (London, United Kingdom)

Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Number: 2

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Mercer (London, United Kingdom). Modeling in vitro, ex vivo or in vivo?. Research Seminar 2013 - Optimising models for human lung diseases and drug development

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Non-viral and viral gene transfer in ex vivo and in vivo lung models
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Comparison of drug delivery from spacers using a standard in vitro and an ex vivo method
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014



Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019


Characterisation of an ex vivo model of human airway epithelium
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019


Alteration of the inflammatory response in blood ex vivo in pig farmers
Source: Eur Respir J 2006; 28: Suppl. 50, 567s
Year: 2006

A human-like ex vivo preclinical model for aerosol deposition studies
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Development of in vitro assays to predict fibrogenesis and replace animal testing
Source: Eur Respir J 2006; 28: Suppl. 50, 521s
Year: 2006

Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



In vitro generation and culture of human dendritic cells experimental model
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007


Imaging of animal models: in vivo we can learn more
Source: Annual Congress 2008 - Computer-aided imaging of lung parenchyma and airways
Year: 2008


Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Improving donor organ quality: the role of ex vivo lung perfusion
Source: International Congress 2019 – ME2 Improving donor organ quality: the role of ex vivo lung perfusion
Year: 2019


Potential therapeutic targets for lung repair during human ex vivo lung perfusion
Source: Eur Respir J, 55 (4) 1902222; 10.1183/13993003.02222-2019
Year: 2020



In vitro and in vivo laboratory models of pleural disease
Source: Eur Respir Monogr 2020; 87: 29-47
Year: 2020


Hemodynamic and respiratory assessement of an ex vivo perfused rat lung model
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014

Effect of human neutrophil proteases on ex vivo small airway function
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013

Ex vivo donor lung perfusion
Source: School Course 2012 - Lung Transplantation
Year: 2012


Assessment of pulmonary drug delivery in ex vivo mouse lungs using quantitative 3D fluorescence imaging
Source: International Congress 2014 – From lung imaging research to clinical use
Year: 2014

Toxicological and inflammatory effects of electronic cigarette extracts using in vitro and ex vivo lung models
Source: International Congress 2016 – Electronic cigarettes
Year: 2016